Parkinson's Disease clinical trials
Showing 51–100 of 314 active trials. Describe your situation to see which ones look like a fit.
- Accelerated TMS for Apathy in PD
- Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
- Spinal Cord Stimulation for Parkinson's Disease Rehabilitation
- Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
- Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
- Ketamine for Veterans With Parkinson's Disease
- Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease
- Pyridostigmine for the Treatment of Constipation in Parkinson Disease
- Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
- Electrophysiology-based DBS Programming for PD
- Light Therapy Intervention in Individuals With Parkinson's Disease
- A Study of Buntanetap in Participants With PD
- Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients
- Use of CereGate Therapy for Freezing of Gait in PD
- TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD
- Multicontext Approach for Cognitive Function in Parkinson Disease
- Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Listener Training for Improved Intelligibility of People With Parkinson's Disease
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms
- Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
- A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease
- Imaging Biomarkers of FOG Response to DBS
- Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD
- Psilocybin Therapy for Depression in Parkinson's Disease
- Robotic Apparel to Prevent Freezing of Gait in Parkinson Disease
- Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
- Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
- Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
- Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
- Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
- Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial
- WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity
- Investigating Inhibitory Control Networks in Parkinson's Disease
- Alternative Therapies for Improving Physical Function in Individuals With Stroke
- Correlation of STN-DBS Induced Visuospatial Changes and Freezing of Gait
- Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
- Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
- Deep Brain Stimulation Therapy in Movement Disorders
- Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
- Deep Brain Stimulation Surgery for Movement Disorders
- Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
- CPAP for the Treatment of Supine Hypertension
- Mindfulness Walking Intervention to Enhance Resilience (iWalk)
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
- Impact of a Biophoton Therapy on Patients With Brain Disorders
- Neurologic Stem Cell Treatment Study
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.